Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Nandini Pal Basak"'
Autor:
Nandini Pal Basak, Kowshik Jaganathan, Biswajit Das, Oliyarasi Muthusamy, Rajashekar M, Ritu Malhotra, Amit Samal, Moumita Nath, Ganesh MS, Amritha Prabha Shankar, Prakash BV, Vijay Pillai, Manjula BV, Jayaprakash C, Vasanth K, Gowri Shankar K, Sindhu Govindan, Syamkumar V, Juby, Koushika R, Chandan Bhowal, Upendra Kumar, Govindaraj K, Mohit Malhotra, Satish Sankaran
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-15 (2024)
Abstract Dynamic interactions within the tumor micro-environment drive patient response to immune checkpoint inhibitors. Existing preclinical models lack true representation of this complexity. Using a Head and Neck cancer patient derived TruTumor hi
Externí odkaz:
https://doaj.org/article/9dbb8fcc65214595a787b6c11342d00b
Autor:
Satish Sankaran, Nandini Pal Basak, Sindhu Govindan, BV Prakash, BV Manjula, MS Ganesh, Amritha Prabha, Kowshik Jaganathan, K Vasanth, K Gowri Shankar, A Manimaran, M Rajashekar, Ritu Malhotra, M Oliyarasi, Rachita Rao
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/fa741d849d444f21960e8e19e0969f79
Autor:
Satish Sankaran, Kowshik Jaganathan, Gowri Shankar K, Saurabh Bhargav, Ganesh MS, Amritha Prabha, Prakash BV, Syamkumar V, Biswajit Das, Vasanth K, Manimaran A, Chandan Bhowal, Rajashekar M, Oliyarasi M, Ritu Malhotra, Govindraj K, Nandini Pal Basak
Publikováno v:
Cancer Research. 83:4568-4568
Tyrosine Kinase Inhibitors (TKIs) and Immune checkpoint inhibitors (ICIs) are used in first line treatment of clear cell renal cell carcinoma (ccRCC). Identifying patients who truly benefit from these treatments remains a challenge. Developing newer
Autor:
Barbara Cipriani, Alastair Corbin, David Miller, Alan Naylor, Faraz Khan, Gavin Milne, Barbara Young, Rupert Satchell, Sourav Sarkar, Mussa Quareshy, Anastasia Nika, Preeti Singh, Gavin Knox, Darryl Turner, Satish Sankaran, Nandini Pal Basak, Toszka Bohn, Tobia Bopp, Surya Koturan, Bo Sun, Benjamin Fairfax, Tom McCarthy, Stuart Hughes
Publikováno v:
Cancer Research. 83:668-668
Whilst the advent of Immune Checkpoint Blockade has revolutionized the management of cancer, a significant proportion of patients have limited or absent response to these therapies. A key cause of this immune insensitivity is the hostile solid tumor
Autor:
BV Prakash, A Manimaran, M Oliyarasi, M Rajashekar, Ritu Malhotra, Ganesh, K Gowri Shankar, BV Manjula, Krishnan Vasanth, Satish Sankaran, Kowshik Jaganathan, Rachita Rao, Nandini Pal Basak, Sindhu Govindan, Amritha Prabha
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundA 3D histo-culture platform provides a near native Tumor immune Micro-Environment (TiME), making it best suited for evaluating response to immunotherapy drugs. Farcast™ TiME is a human 3D tumor histo-culture platform that preserves TiME a
Autor:
Ritu Malhotra, Satish Sankaran, Kowshik Jaganathan, Sindhu Govindan, Nandini Pal Basak, Vasanth K, Pradeep Kumar Kar, Rachita Rao
Publikováno v:
Cancer Research. 81:2767-2767
There is an unmet need for robust and accurate preclinical model to minimize translational failure especially in immuno-oncology (IO) research. The poor correlation between preclinical data with clinical trials remains a major concern. A near native
Autor:
Jason Wall, Manimaran Manickam, Nandini Pal Basak, Misti Jain, Sampratha Bhagyashekar, Anupam Nath, Shivani Vignesh, Debika Datta
Publikováno v:
Cancer Research. 80:4990-4990
Characterization of the tumor microenvironment (TME) is expected to be critical in informing prognosis and guiding response prediction1,2. Recent studies have classified the TME based on tumor infiltrating leukocytes (TILs), programmed death-ligand 1
Autor:
Nandini Pal Basak, Subrata Banerjee
Publikováno v:
Mitochondrion. 21:41-48
Acute myeloid leukemia (AML) is a clonal hematopoietic malignant disorder which arises due to dysregulated differentiation, uncontrolled growth and inhibition of apoptosis leading to the accumulation of immature myeloid progenitor in the bone marrow.
Publikováno v:
Journal of Biological Chemistry. 289:7320-7334
The Notch signaling pathway, a known regulator of cell fate decisions, proliferation, and apoptosis, has recently been implicated in the regulation of glycolysis, which affects tumor progression. However, the impact of Notch on other metabolic pathwa
Publikováno v:
Experimental Cell Research. 320:69-78
Erythropoiesis is a tightly regulated process dependent on extrinsic signals conveyed by the bone marrow niche. The signalling pathways thus activated or repressed do not act in isolation; rather an intricate cross talk among these pathways ensues ho